Cargando…
Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
Chronic pain is an enormous modern public health problem, with significant numbers of people debilitated by chronic pain from a variety of etiologies. Translocator protein 18 kDa (TSPO) was discovered in 1977 as a peripheral benzodiazepine receptor. It is a five transmembrane domain protein, mainly...
Autores principales: | Liu, Jie, Huang, Jingyao, Zhang, Zhenjiang, Zhang, Rui, Zhang, Zhihao, Liu, Yongxin, Ma, Baoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444456/ https://www.ncbi.nlm.nih.gov/pubmed/36071748 http://dx.doi.org/10.1155/2022/8057854 |
Ejemplares similares
-
18 kDa Translocator Protein TSPO Is a Mediator of
Astrocyte Reactivity
por: Tournier, Benjamin B., et al.
Publicado: (2023) -
Translocator Protein 18 kDa (TSPO) Is Regulated in White and Brown Adipose Tissue by Obesity
por: Thompson, Misty M., et al.
Publicado: (2013) -
A Novel Interaction of Translocator Protein 18 kDa (TSPO) with NADPH Oxidase in Microglia
por: Loth, Meredith K., et al.
Publicado: (2020) -
In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease
por: Schollhammer, Romain, et al.
Publicado: (2021) -
Regulation of Translocator Protein 18 kDa (TSPO) Expression in Rat and Human Male Germ Cells
por: Manku, Gurpreet, et al.
Publicado: (2016)